PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)

Clinical trial NCT00043368 · COMPLETED

Trial details

NCT number: NCT00043368
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Breast Neoplasms Carcinoma, Renal Cell Lymphoma, T-Cell Carcinoma, Non-Small-Cell Lung

Start date: 2002-09-01
Primary completion: 2007-06-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.